ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2042

A Low FODMAP Diet Is Not Associated with Decreased GI Symptoms or Changes in GI Microbial Composition in Patients with Systemic Sclerosis

Natalie Howlett1, Sungeun Lee1, Venu Lagishetty1, Zsuzsanna McMahan2, Meifang Wu1, Jonathan Jacobs1 and Elizabeth Volkmann3, 1University of California, Los Angeles, Los Angeles, 2Johns Hopkins University, Baltimore, 3University of California, Los Angeles, Los Angeles, CA

Meeting: ACR Convergence 2020

Keywords: diet, microbiome, nutrition, Scleroderma, Systemic

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Systemic Sclerosis & Related Disorders – Clinical II: Lessons Learned from Clinical Trials & Cohorts (2038–2042)

Session Type: Abstract Session

Session Time: 4:00PM-4:50PM

Background/Purpose: Dietary restriction of short-chain fermentable oligosaccharides, disaccharides, monosaccharides and polyols (low FODMAP) has been found to reduce GI symptoms in patients with IBS and is often recommended to patients with SSc. However, no studies have evaluated whether a low FODMAP diet leads to a meaningful improvement in GI symptoms in patients with SSc. The purpose of this study was to (1) compare GI symptoms in SSc patients adhering to a low versus high FODMAP diet, and (2) determine whether GI microbial composition is altered in SSc patients adhering to a low FODMAP diet.

Methods: Adult patients satisfying the 2013 ACR/EULAR Classification Criteria for SSc provided stool samples for 16S rRNA sequencing. Participants completed the Diet History Questionnaire (DHQ) II, a valid, 153-item food frequency questionnaire that assesses dietary recall in the past month. Forty DHQ II items were characterized as high FODMAP items using the Monash University FODMAP food database. Patients were dichotomized into low versus high FODMAP groups, and GI symptoms, as measured by the UCLA GIT 2.0, were compared between the two groups. Microbial community differences between the low and high FODMAP groups were assessed using 3 metrics of alpha diversity (richness, evenness, phylogenetic diversity), as well as beta diversity. Multivariate negative binomial models were used to identify differentially abundant bacterial genera in the high versus low FODMAP groups.

Results: Patients in the low (N=19) and high (N=16) FODMAP groups were similar in terms of age, %female, BMI, disease duration, %diffuse disease, smoking history and %small intestine bacterial overgrowth [SIBO] (Table 1). There were no significant differences in GIT 2.0 scores between the low and high FODMAP groups, although the scores for some of the domains (e.g., Reflux, Distension, Diarrhea) were numerically higher in the high FODMAP group; whereas scores for the constipation domain were similar for both groups. There were no significant differences in alpha diversity between the two groups on both univariate and multivariate analysis controlling for age, sex, SSc subtype, smoking, SIBO and disease duration. There was no significant difference in beta diversity between the two groups on univariate and multivariate analysis (Figure 1). Compared with the low FODMAP group, the high FODMAP group had increased abundance of Enterococcus, a genus considered in a number of studies to be pathobiont (Figure 2); however, in the multivariate analysis, there was no significant genus level differences between the two groups with the exception of Parvimonas enrichment in the low FODMAP group.

Conclusion: Evidenced-based dietary recommendations for SSc are lacking. This is the first study to examine the relationship between diet, GI symptoms, and GI microbial composition in patients with SSc.  Although this was a small study, the results demonstrate that consuming a low FODMAP diet is not associated with significant alterations GI microbial composition, nor significant improvements in SSc-GI symptoms. Larger, prospective SSc-GI studies are needed to help guide the clinical management of this troubling and understudied dimension of SSc.  

Table 1. Demographics, clinical characteristics and GIT 2.0 scores of SSc patients.

Figure 1. Beta diversity of the High (Red) and Low (blue) FODMAP group patients as demonstrated by principal coordinate analysis plots of the robust Aitchison distance. Each dot represents a patient sample. The P-value (0.264) was calculated by analysis of variance using distance matrices.

Figure 2. Genus level taxa with significant (q < 0.1) differential abundance between low versus high FODMAP groups. Circles with a positive fold change represent genera with increased abundance in the high FODMAP group, and circles with a negative fold change represent genera with increased abundance in the low FODMAP group. The color of the circle signifies the phylum level of the genera with differential abundance. The size of the circle indicates the relative abundance of the specific genus.


Disclosure: N. Howlett, None; S. Lee, None; V. Lagishetty, None; Z. McMahan, None; M. Wu, None; J. Jacobs, None; E. Volkmann, Boehringer Ingelheim, 2, 5, Forbius, 2, 5, Corbus, 2.

To cite this abstract in AMA style:

Howlett N, Lee S, Lagishetty V, McMahan Z, Wu M, Jacobs J, Volkmann E. A Low FODMAP Diet Is Not Associated with Decreased GI Symptoms or Changes in GI Microbial Composition in Patients with Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/a-low-fodmap-diet-is-not-associated-with-decreased-gi-symptoms-or-changes-in-gi-microbial-composition-in-patients-with-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-low-fodmap-diet-is-not-associated-with-decreased-gi-symptoms-or-changes-in-gi-microbial-composition-in-patients-with-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology